Novel transcatheter heart valve may be effective for management of high-risk aortic regurgitation
1. The 30-day composite primary safety endpoint of > 40.5% was achieved for Trilogy TAVI. 2. 8% of patients who ...
1. The 30-day composite primary safety endpoint of > 40.5% was achieved for Trilogy TAVI. 2. 8% of patients who ...
1. In this randomized crossover trial, intravenous levothyroxine, given to hemodynamically unstable brain-dead potential heart donors, did not improve the ...
1. Redo-TAVR had low procedural complication rates and was comparable to native-TAVR in terms of risk of death and stroke ...
1. Postoperative enhanced recovery after surgery (ERAS) protocols for cardiac surgeries were found to improve outcomes such as decreasing the ...
1. In this randomized controlled trial, patients who received transcatheter repair of mitral regurgitation secondary to cardiomyopathy had good safety ...
1. In this randomized controlled trial, patients who received transcatheter repair of mitral regurgitation secondary to cardiomyopathy had good safety ...
1. In this open-label randomized trial, percutaneous tricuspid transcatheter edge-to-edge repair (TEER) reduced severe tricuspid regurgitation and improved quality of ...
1. A cluster of four cardiac surgery patients were found to have Mycobacterium abscessus infections on the same floor at ...
1. In this randomized clinical trial of 1416 adult cardiac surgery patients, high-dose selenium did not increase the number of ...
1. In this within-trial economic evaluation of the Fibrinogen Replenishment in Surgery (FIBERS) randomized clinical trial, the median total 7-day ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.